# A Study of Stellate Ganglion Block for Prevention of Atrial Fibrillation

Study · id `cardio:ct-nct05357690` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05357690](<https://clinicaltrials.gov/study/NCT05357690>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05357690

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

## Technical summary

Registry record NCT05357690. Randomized; quadruple masking; primary purpose prevention. Start 2023-04-19 (actual); primary completion 2026-06-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 2/3
- Enrolled: 200 participants (enrolled count; ClinicalTrials.gov record NCT05357690, source copy `cardio:ctgov-nct05357690-2026-07-10`, retrieved 2026-10-26)
- Started: 2023-04-19 (actual) (ClinicalTrials.gov record NCT05357690, source copy `cardio:ctgov-nct05357690-2026-07-10`, retrieved 2026-10-26)
- Primary completion: 2026-06-08 (actual) (ClinicalTrials.gov record NCT05357690, source copy `cardio:ctgov-nct05357690-2026-07-10`, retrieved 2026-10-26)
- Completion: 2026-06-08 (actual) (ClinicalTrials.gov record NCT05357690, source copy `cardio:ctgov-nct05357690-2026-07-10`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05357690, source copy `cardio:ctgov-nct05357690-2026-07-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05357690-2026-07-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study of Stellate Ganglion Block for Prevention of Atrial Fibrillation
- Condition: Atrial Fibrillation
- Intervention (Procedure): Stellate ganglion block
- Intervention (Drug): Bupivacaine
- Intervention (Drug): Placebo
- Lead sponsor: Mayo Clinic
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Mayo Clinic (`cardio:org-mayo-clinic`)

## Provenance

Content hash: 75e1a86f04a413fc39f958bb919a99590e30340cca06494d16f5b4cbdf9547ad
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
